|
ONC201 in previously-irradiated pediatric H3 K27M-mutant glioma. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Neon Therapeutics |
Consulting or Advisory Role - Cota Healthcare |
Patents, Royalties, Other Intellectual Property - Fused Bicyclic Heterocycles as Therapeutic Agents (Inventor) Provisional Patent Application No. 62/742,041 filed on October 5, 2018 |
Travel, Accommodations, Expenses - Abbvie |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Oncoceutics |
| |
|
|
|
Stock and Other Ownership Interests - Oncoceutics |
| |
|
|
|
Stock and Other Ownership Interests - Oncoceutics |
| |
|
No Relationships to Disclose |